Distribution of hepatitis C virus genotypes in the Middle East

International Journal of Infectious Diseases

Volumn 10, Issue 4, 2006, Pages 272-277

  Ramia, S ^a   Eid Fares, J ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Epidemiology; Genotypes; Hepatitis C virus; Middle East

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C VACCINE; INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ARAB; BODY BURDEN; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG USE; EUROPE; FATALITY; GENETIC ORGANIZATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MIDDLE EAST; NONHUMAN; PREVALENCE; REVIEW; TREATMENT OUTCOME; VIRUS GENOME; WESTERN HEMISPHERE; WORLD HEALTH ORGANIZATION;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MIDDLE EAST;

EID: 33745016896     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2005.07.008     Document Type: Review

References (98)

1. World Health Organization. Hepatitis C-global prevalence (update). Wkly Epidemiol Rec 49 (1999) 425-427
2. National Institutes of Health Consensus Development Conference Panel Statement. Management of hepatitis C. Hepatology 26 (1997) S2-S10
3. Seeff L.B. Natural history of viral hepatitis, type C. Semin Gastrointest Dis 6 (1995) 20-27
4. Di Bisceglie A.M. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 15 (1995) 64-69
5. Kuo G., Choo Q.L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244 (1989) 362-364
6. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
7. Higuchi M., Tanaka E., and Kiyosawa K. Epidemiology and clinical aspects of hepatitis C. Jpn J Infect Dis 55 (2002) 69-77
8. Farci P., and Purcell R. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 20 (2000) 103-126
9. Mondelli M.U., and Silini E. Clinical significance of hepatitis C virus genotypes. J Hepatol 31 Suppl. 1 (1999) 65-70
10. Al-Faleh F., Ramia S., and Hepatitis. C virus infection in Saudi Arabia: a review. Ann Saudi Med 17 (1997) 77-82
11. Zein N.N. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13 (2000) 223-235
12. Nguyen M.H., and Keeffe E.B. Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Rev Gastroenterol Disord 4 Suppl. 1 (2004) S14-S21
13. Koshy A., Madda J.P., Marcellin P., and Martinot M. Treatment of hepatitis C virus genotype 4-related cirrhosis: ribavirin and interferon combination compared with interferon alone. J Clin Gastroenterol 35 (2002) 82-85
14. Shiha G., and Salem S. Interferon alone or in combination with ribavirin for the treatment of chronic hepatitis C genotype IV. J Hepatol 36 (2002) 129
15. Shobokshi O.A., Serebour F.E., and Shakni L. Chronic hepatitis C treatment: a review. Ann Saudi Med 20 (2000) 402-408
16. Choo Q.L., Kuo G., Weiner A.J., Overky L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
17. Houghton M. Hepatitis C virus. In: Fields B.N., Knipe D.M., Howley P.M., and Chanock R.H. (Eds). Fields virology. 3rd ed. (1996), Lippincott-Raven, Philadelphia 1035-1058
18. Tanaka T., Kato N., Cho M., and Shimotohno K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem Biophys Res Commun 215 (1995) 744-749
19. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88 (1991) 2451-2455
20. Weiner A.J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180 (1991) 842-848
21. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Ohkoshi S., and Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 175 (1991) 220-228
22. Simmonds P. Variability of hepatitis C virus. Hepatology 21 (1995) 570-583
23. Tokita H., Okamoto H., Tsuda F., Song P., Nakata S., Chosa T., et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth and ninth major genetic groups. Proc Natl Acad Sci USA 91 (1994) 11022-11026
24. Tokita H., Okamoto H., Luengrojanakul P., Vareesangthip K., Chainuvati T., Iizuka H., et al. Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol 76 (1995) 2329-2335
25. Mizokami M., Gojobori T., Ohba K., Ikeo K., Ge X.M., Ohno T., et al. Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes. J Hepatol 24 (1996) 622-624
26. Schreier E., Roggendorf M., Driesel G., Hohne M., and Viazov S. Genotypes of hepatitis C virus isolates from different parts of the world. Arch Virol 11 Suppl. (1996) 185-193
27. Ross R.S., Viazov S.O., Holtzer C.D., Beyou A., Monnet A., Mazure C., et al. Genotyping of hepatitis C virus isolates using CLIP sequencing. J Clin Microbiol 38 (2000) 3581-3584
28. Nakao T., Enomoto N., Takada N., Nakao T., Enomoto N., Takada N., et al. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 72 Pt 9 (1991) 2105-2112
29. Le Pogam S., Dubois F., Christen R., Raby C., Cavicchini A., and Goudeau A. Comparison of DNA enzyme immunoassay and line probe assays (InnoLiPA HCV I and II) for hepatitis C virus genotyping. J Clin Microbiol 36 (1998) 1461-1463
30. Pawlotsky J.M. Use and interpretation of virological tests for hepatitis C. Hepatology 36 (2002) S65-S73
31. Pawlotsky J.M., Prescott L., Simmonds P., Pellet C., Laurent-Puig P., Labonne C., et al. Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Microbiol 35 (1997) 1734-1739
32. Cerino A., Cividini A., Asti M., Lanza A., Silini E., and Mondelli M.U. Comparative evaluation of two serologic typing methods of hepatitis C virus. J Clin Microbiol 34 (1996) 714-716
33. Bhattacherjee V., Prescott L.E., Pike I., Rodgers B., Bell H., El-Zayadi A.R., et al. Use of NS-4 peptides to identify type-specific antibody to genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 76 (1995) 1737-1748
34. McOmish F., Yap P.L., Dow B.C., Follett E.A., Seed C., Keller A.J., et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32 (1994) 884-892
35. Silini E., and Mondelli M.U. Significance of hepatitis C virus genotypes. Viral Hepat Rev 1 (1995) 111-120
36. Mahaney K., Tedeschi V., Maertens G., Di Bisceglie A.M., Vergalla J., Hoofnagle J.H., et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 20 (1994) 1405-1411
37. McOmish F., Chan S.W., Dow B.C., Gillon J., Frame W.D., Crawford R.J., et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33 (1993) 7-13
38. Nousbaum J.-B., Pol S., Nalpas B., Landais P., Berthelot P., Brechot C., and Group Collaborative Study. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 122 (1995) 161-168
39. Viazov S., Kuzin S., Paladi N., Tchernovetsky M., Isaeva E., Mazhul L., et al. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 53 (1997) 36-40
40. Osella A.R., Sonzogni L., Cavallini A., Foti L., Guerra V., Di Leo A., et al. Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. J Clin Microbiol 37 (1999) 2371-2372
41. Silini E., Bono F., Cividini A., Cerino A., Maccabruni A., Tinelli C., et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 22 (1995) 691-695
42. Pol S., Thiers V., Nousbaum J.B., Legendre C., Berthelot P., Kreis H., et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108 (1995) 581-583
43. Pawlotsky J.M., Tsakiris L., Roudot-Thoraval F., Pellet C., Stuyver L., Duval J., et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171 (1995) 1607-1610
44. Djebbi A., Triki H., Bahri O., Cheikh I., Sadraoui A., Ben Ammar A., et al. Genotypes of hepatitis C virus circulating in Tunisia. Epidemiol Infect 130 (2003) 501-505
45. Benani A., El-Turk J., Benjelloun S., Sekkat S., Nadifi S., Hda N., et al. HCV genotypes in Morocco. J Med Virol 52 (1997) 396-398
46. Cacoub P., Ohayon V., Sekkat S., Dumont B., Sbai A., Lunel F., et al. Epidemiologic and virologic study of hepatitis C virus infection in Morocco. Gastroenterol Clin Biol 24 (2000) 169-173
47. Ray S.C., Arthur R.R., Carella A., Bukh J., and Thomas D.L. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182 (2000) 698-707
48. Xu L.Z., Larzul D., Delaporte E., Brechot C., and Kremsdorf D. Hepatitis C virus genotype 4 is highly prevalent in Central Africa (Gabon). J Gen Virol 75 Pt 9 (1994) 2393-2398
49. Oni A.D., and Harrison T.J. Genotypes of hepatitis C virus in Nigeria. J Med Virol 49 (1996) 178-186
50. Njouom R., Pasquier C., Ayouba A., Gessain A., Froment A., Mfoupouendoun J., et al. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71 (2003) 219-225
51. Smuts H.E., and Kannemeyer J. Genotyping of hepatitis C virus in South Africa. J Clin Microbiol 33 (1995) 1679-1681
52. Simmonds P., Mellor J., Sakuldamrongpanich T., Nuchaprayoon C., Tanprasert S., Holmes E.C., et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol 77 Pt 12 (1996) 3013-3024
53. Mellor J., Walsh E.A., Prescott L.E., Jarvis L.M., Davidson F., Yap P.L., et al. Survey of type 6 group variants of hepatitis V virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 34 (1996) 417-423
54. Sugiyama K., Kato N., Nakazawa T., Yonemura Y., Phornphutkul K., Kunakorn M., et al. Novel genotypes of hepatitis C virus in Thailand. J Gen Virol 76 Pt 9 (1995) 2323-2327
55. Tokita H., Okamoto H., Tsuda F., Song P., Nakata S., Chosa T., et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 91 (1994) 11022-11026
56. Tokita H., Okamoto H., Iizuka H., Kishimoto J., Tsuda F., Miyakawa Y., et al. The entire nucleotide sequences of three hepatitis V virus isolates in genetic groups 79 and comparison with those in the other eight genetic groups. J Gen Virol 79 Pt 8 (1998) 1847-1857
57. Tokita H., Okamoto H., Iizuka H., Kishimoto J., Tsuda F., Lesmana L.A., et al. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol 77 Pt 2 (1996) 293-301
58. Katayama Y., Barzaga N.G., Alipio A., Soetjipto, Doi H., Ishido S., et al. Genotype analysis of hepatitis C virus among blood donors and inmates in Metro Manila, The Philippines. Microbiol Immunol 40 (1996) 525-529
59. Chamberlain R., Adams N., Saeed A., Simmonds P., and Elliot R. Complete nucleotide sequence of a type 4 hepatitis C virus variant. The predominant genotype in the Middle East. J Gen Virol 78 (1997) 1341-1347
60. Fakeeh M., and Zaki A.M. Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia. Am J Trop Med Hyg 61 (1999) 889-892
61. Ray S.C., Arthur R.R., Carella A., Bukh J., and Thomas D.L. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182 (2000) 698-707
62. Shemer-Avni Y., el Astal Z., Kemper O., el Najjar K.J., Yaari A., Hanuka N., et al. Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip. J Med Virol 56 (1998) 230-233
63. Bdour S. Hepatitis C virus infection in Jordanian hemodialysis units: serological diagnosis and genotyping. J Med Microbiol 51 (2002) 200-204
64. Pasca A., Al-Mufti S., Chugh T., and Said-Adi G. Genotypes of hepatitis C virus in Kuwait. Med Princ Pract 10 (2001) 55-57
65. Ramia S., Koussa S., Taher A., Haraki S., Klayme S., Sarkis D., et al. Hepatitis C virus genotypes and hepatitis G virus infection in Lebanese thalassemics. Ann Trop Med Parasitol 96 (2002) 197-202
66. Sharara AI, Ramia S, Ramlawi F, Eid Fares J, Klayme S, Naman R. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect; accepted for publication.
67. Al-Ahdal M., Rezeig M., and Kessie G. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome. Ann Saudi Med 17 (1997) 601-604
68. Shobokshi O.A., Serebour F.E., and Skakni L.L. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia. Saudi Med J 24 Suppl. 2 (2003) S87-S91
69. Shobokshi O.A., Serebour F.E., Skakni L., Al-Saffy Y.H., and Ahdal M.N. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 58 (1999) 44-48
70. Osoba A. Hepatitis C virus genotypes in the Kingdom of Saudi Arabia. Saudi Med J 23 (2002) 7-12
71. Abdulkarim A.S., Zein N.N., Germer J.J., Kolbert C.P., Kabbani L., Krajnik K.L., et al. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis V virus subtypes. Am J Trop Med Hyg 50 (1998) 571-576
72. Sawant P., Upadhyay A.P., Levicnik-Stezinar S., Zali M.R., and Okamoto H. Genotypes of GB virus C and hepatitis C virus in hepatitis patients in India, Iran and Slovenia. Hepatology Res 10 (1998) 175-183
73. Samimi-Rad K., Nategh R., Malekzacleh R., Norder H., and Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol 74 (2004) 246-252
74. Weinstein T., Tur-Kaspa R., Chagnac A., Korzets A., Ori Y., Zevin D., et al. Hepatitis C infection in dialysis patients in Israel. Isr Med Assoc J 3 (2001) 174-177
75. Bozdayi G., Rota S., Verdi H., Derici U., Sindel S., Bali M., et al. The presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotype distribution. Mikrobiyol Bul 36 (2002) 291-300
76. Bozdayi A.M., Aslan N., Bozdayi G., Turkyilmaz A.R., Sengezer T., Wend U., et al. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 149 (2004) 2115-2129
77. Argentini C., Dettori S., Villano U., Guadagnino V., Infantolino D., Dentico P., et al. Molecular characterization of HCV genotype 4 isolates circulating in Italy. J Med Virol 62 (2000) 84-90
78. Matera G., Lamberti A., Quirino A., Foca D., Giancotti A., Barreca G.S., et al. Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis 42 (2002) 169-173
79. Sanchez-Quijano A., Abad M.A., Torronteras R., Rey C., Pineda J.A., Leal M., et al. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 27 (1997) 25-29
80. Schroter A., Zollner B., Schafer P., Reimer A., Muller M., and Laufs R. Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance. J Clin Microbiol 40 (2002) 1866-1868
81. De Ledinghen V, Trimoulet P, Castera L. Unexpected high prevalence of HCV genotype 4 infection in a French Caucasian population. Proceedings of the 53rd Annual Meeting of the American Association for the Study of Liver Diseases; 2002 Nov 1-5; Boston, MA, USA. Orlando, USA: WB Saunders Co.; 2002.
82. Lyra A., Ramrakhiani S., Bacon B., and Di Bisceglie A. Infection with hepatitis C virus genotype 4 in the United States. J Clin Gastroenterol 38 (2004) 68-71
83. Raghuraman S., Abraham P., Sridharan G., Daniel H., Rama-Krishna B.S., and Shaji R. HCV genotype 4 - an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 31 (2004) 253-258
84. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., et al. Interferon-alpha 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339 (1998) 1485-1492
85. Poynard T., Marcellin P., Lee S.S., Niederau C., Minuk G.S., Ideo G., et al. Randomized trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. Lancet 352 (1998) 1426-1432
86. Okanoue T., Itoh Y., Minami M., Sakamoto S., Yasui K., Sakamoto M., et al. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in advanced stage: a retrospective study in 1148 patients. J Hepatol 30 (1999) 653-659
87. Booth J.C.L., O'Grady J., Neukerger J., and on behalf of the Royal College of Physicians of London and the British Society of Gastroenterology. Clinical guidelines on the management of hepatitis C. Gut 49 Suppl. 1 (2001) i1-i21
88. Al-Faleh F.Z., Aljumah A., Rezeig M., Al-Kanawi, Al-Otaibi M., Alahdal M., et al. Treatment of chronic hepatitis C genotype IV with interferon-ribavirin combination in Saudi Arabia: a multicentre study. J Viral Hepat 7 (2000) 287-291
89. Shiha G., and Salem S. Interferon alone or in combination with ribavirin for the treatment of chronic hepatitis C genotype IV. J Hepatol 36 (2002) 129
90. Koshy A., Madda J.P., Marcellin P., and Martinot M. Treatment of hepatitis C virus genotype 4-related cirrhosis: ribavirin and interferon combination compared with interferon alone. J Clin Gastroenterol 35 (2002) 82-85
91. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
92. Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., et al. Peginterferon α-2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose. Ann Intern Med 140 (2004) 346-355
93. Diago M., Hassanein T., Rodes J., Ackrill A.M., and Sedarati F. Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin [Letter]. Ann Intern Med 140 (2004) 72-73
94. Hasan F., Asker H., Al Khaldi J., Siddique I., Al-Ajmi M., Owaid S., et al. Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Am J Gastroenterol 99 (2004) 1733-1737
95. Shobokshi O.A., Serebour F.E., Skakni L., Al-Jaser N., Tantawe A.O., Sabah A., et al. Pegylated interferon alfa-2a (40KDA) as a monotherapy or in combination with ribavirin significantly improves end of treatment response rate in hepatitis C virus genotype 4 chronic active hepatitis patients. Saudi Med J 24 (2003) S92-S192
96. Shobokshi O.A., Serebour F.E., Skakni L., Al-Jaser N., Tantawe A.O., Sabah A., et al. Early virological response at week 12 has positive predictive value for end of treatment response for hepatitis C virus genotype 4 chronic active hepatitis cases treated with combination therapy of pegylated interferon plus ribavirin. Saudi Med J 24 (2003) S92-S93
97. Khuroo M.S., Khuroo M.S., and Dahab S.T. Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4. Aliment Pharmacol Ther 20 (2004) 931-938
98. Zylberberg H., Chaix M.L., and Brechot C. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha [Letter]. Ann Intern Med 132 (2000) 845-846